Cynosure Lutronic Executive and Leadership Team

Nadav Tomer, the Chief Executive Officer at Cynosure Lutronic, directs the overarching strategic vision for the development of energy-based aesthetic and medical treatment systems. Overseeing the global product roadmap, the Chief Executive Officer ensures that manufacturing processes align with the evolving needs of physicians and aesthetic business owners. This leadership role involves driving market penetration across diverse treatment applications, including hair removal and skin revitalization. By fostering a culture of innovation, Nadav Tomer maintains the company's position as a leader in medical technology. The Chief Executive Officer collaborates with the board to secure long-term growth, while Tomer monitors international market trends to refine the company's competitive edge. Through rigorous operational oversight, the Chief Executive Officer guarantees that all product lines meet the highest standards of clinical efficacy and safety for patients worldwide.

Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure Lutronic, manages the specialized photonics division critical to the company's energy-based treatment platforms. Directing the integration of advanced laser technologies, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc optimizes the manufacturing pipeline for high-precision medical devices. This role involves coordinating with research teams to translate complex optical engineering into practical solutions for scar reduction and gynecological health. Timothy Gehlmann ensures that the technical infrastructure supports the broader corporate mission of delivering best-in-class aesthetic systems. By streamlining production efficiencies, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc enhances the scalability of the company's product portfolio. Gehlmann maintains strict quality control protocols, ensuring that every photonics component meets the rigorous demands of global medical practitioners.

Cyriacus Njoku, the Chief Executive Officer & President at Cynosure Lutronic, leads the execution of enterprise-wide initiatives focused on expanding the reach of energy-based medical treatment systems. Overseeing the alignment of business units, the Chief Executive Officer & President drives the implementation of strategies that support body contouring and skin revitalization product lines. This leadership role involves managing cross-functional teams to ensure that the company's medical devices remain at the forefront of the aesthetic industry. Cyriacus Njoku facilitates communication between departments to optimize resource allocation and improve operational agility. By analyzing market data, the Chief Executive Officer & President identifies new opportunities for growth within the global medical community. Njoku ensures that the company's commitment to innovation translates into tangible value for practitioners and patients alike, while the Chief Executive Officer & President maintains a focus on sustainable business practices.

Bob Howe, the Chief Financial Officer at Cynosure Lutronic, manages the financial health and fiscal strategy of the organization. Overseeing capital allocation, the Chief Financial Officer ensures that investments in research and development for energy-based treatment systems remain robust and aligned with long-term growth objectives. This role involves directing financial planning, reporting, and risk management to support the company's global manufacturing operations. Bob Howe collaborates with other executive leaders to evaluate the profitability of new product launches in the aesthetic and medical sectors. By optimizing the cost structure, the Chief Financial Officer strengthens the company's ability to compete in international markets. Howe monitors economic indicators to provide strategic guidance on expansion efforts, while the Chief Financial Officer maintains transparency with stakeholders. Through disciplined financial oversight, Howe secures the resources necessary to sustain the company's leadership in medical technology.

Christopher Aronson, the President (North America) at Cynosure Lutronic, directs the commercial strategy and market growth across the North American region. Overseeing sales and distribution networks, the President (North America) ensures that the company's energy-based aesthetic systems reach a wide base of physicians and medical practitioners. This role involves driving regional initiatives to increase the adoption of treatments for body contouring and skin revitalization. Christopher Aronson collaborates with marketing and clinical teams to tailor product messaging to the specific needs of the North American market. By analyzing regional sales performance, the President (North America) identifies opportunities to enhance market share and improve customer engagement. Aronson manages relationships with key accounts and aesthetic business owners, while the President (North America) ensures that regional operations align with the company's global objectives. Through strategic leadership, Aronson strengthens the company's presence and influence within the North American medical aesthetic sector.

Jae Yoo, the Chief Operations Officer at Cynosure Lutronic, directs the end-to-end supply chain and manufacturing processes for the company's diverse range of aesthetic treatment systems. Overseeing global logistics, the Chief Operations Officer ensures that the production of devices for hair removal and skin revitalization meets the high demand of practitioners worldwide. This role involves implementing lean manufacturing principles to enhance efficiency and reduce lead times across all product lines. Jae Yoo coordinates with engineering and procurement teams to maintain a seamless flow of materials and components. By optimizing operational workflows, the Chief Operations Officer supports the company's ability to deliver innovative medical solutions to the market. Yoo monitors performance metrics to identify areas for process improvement, while the Chief Operations Officer ensures that all manufacturing facilities adhere to strict regulatory standards. Through operational excellence, Yoo drives the company's capacity to scale production effectively.

Sean Flanagan, the Chief Legal Officer at Cynosure Lutronic, directs the legal and regulatory strategy for the company's energy-based medical treatment systems. Overseeing intellectual property protection, the Chief Legal Officer ensures that the company's innovations in scar reduction and gynecological health remain secure in a competitive global market. This role involves managing compliance with international medical device regulations to facilitate smooth market entry and ongoing operations. Sean Flanagan provides counsel on corporate governance and risk mitigation to the executive team. By navigating complex legal landscapes, the Chief Legal Officer supports the company's expansion into new geographic regions. Flanagan oversees contract negotiations and legal disputes, ensuring that the company's interests are protected at all times. Through proactive legal management, the Chief Legal Officer enables the business to pursue its mission of delivering advanced aesthetic treatments while maintaining the highest standards of corporate integrity.